Gongye shui chuli, 2021 介绍了某热电厂脱硫废水旁路烟道蒸发系统工程设计开发及其应用情况。通过热力模拟计算分析发现，利用烟气蒸发不能消耗现有全部脱硫废水，需要对脱硫废水进行减量处理。本工程设计采用软化浓缩工艺对脱硫废水进行减量处理，所得淡水回用，而浓盐水去旁路烟道蒸发系统。运行结果表明：反渗透浓水中钙离子浓度控制在4 mmol/L以内，能满足反渗透装置长时间运行；蒸发塔抽取的最大热烟气量可以达到5%~6.5%，蒸发塔运行压差均小于空预器压差；喷枪的耐磨性要好于雾化盘。
袁国全 +3 more
doaj +2 more sources
Gongye shui chuli, 2022 由于燃煤电厂脱硫废水成分复杂，具有含盐量高、腐蚀性强、易结垢等特点，自从“水污染防治行动计划”颁布以后，脱硫废水零排放已逐渐成为电厂污染物深度治理的必然趋势。燃煤电厂脱硫废水零排放处理采用旁路烟道蒸发处理工艺，其具有占地面积小、投资和运行成本低、运维方便、不产生新的固废等优点，已逐渐成为脱硫废水零排放的主流技术。某2×350 MW燃煤电厂采用旁路烟道喷雾干燥蒸发技术对脱硫废水进行零排放处理，每台机组配置2台2 m3/h双向流体雾化蒸发塔。对该工艺系统进行性能试验研究，结果表明蒸发塔喷水量满足设计要求 ...
李亚娟 +5 more
doaj +2 more sources
Gongye shui chuli, 2020 燃煤电厂脱硫废水水量波动大、污染物成分复杂、处理难度大、处理成本高，开发经济高效的脱硫废水处理技术备受关注。综述了传统三联箱、厂内回用和零液体排放3类脱硫废水处理技术的特点，分析了实际工程案例中不同技术的处理效果、工艺参数边界特征、潜在影响及运行成本。实践表明，随着国家环保政策的节节加码，零液体排放技术是脱硫废水处理的主要发展趋势，降低投资与运行成本是未来的研发重点。
张建华 +5 more
doaj +2 more sources
Gongye shui chuli, 2019 燃煤电厂脱硫废水具有含盐量高、成分复杂等特点，处理难度极大，直接排放会对环境造成严重污染。对国内几种具有应用前景的脱硫废水零排放技术进行介绍，分析了不同技术的原理及优缺点。展望了燃煤电厂脱硫废水处理技术的发展趋势，指出利用旁路烟道及旁路喷雾干燥零排放处理技术的优势，在此基础上探索高效清洁、低成本的零排放处理技术将成为脱硫废水排放领域的研究重点。
白璐 +6 more
doaj +2 more sources
[Shenqi Wenfei Formula alleviates chronic obstructive pulmonary disease in rats with pulmonary qi deficiency syndrome by regulating NLRP3/GSDMD pyroptosis pathway]. [PDF]
Nan Fang Yi Ke Da Xue Xue Bao, 2023 Wu D +7 more
europepmc +1 more source
Effects of microRNA-21 on endothelial-to-mesenchymal transition and its role in the pathogenesis of chronic obstructive pulmonary disease. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2023 Liao Y, Zeng Z, Cai J, Sun S, Xie L.
europepmc +1 more source
Role of mucociliary clearance system in respiratory diseases. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2023 Wu D, Xiang Y.
europepmc +1 more source
[Shashen Maidong Decoction Improves Pulmonary Function in Aged Mice With Chronic Obstructive Pulmonary Disease by Inhibiting cGAS-STING-NF-κB-Mediated Inflammaging]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue BanKuang X, Liu X, Zhao X, Chen X, Liu S.
europepmc +1 more source
[Environmental relative humidity, frailty, and risk of incident stroke among middle-aged and older adults in China: A prospective cohort study]. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue BanZhou Y +5 more
europepmc +1 more source
[<i>Sangma Zhike</i> Formula alleviates airway inflammation and hyperresponsiveness in rats with postinfectious cough by inhibiting the TRPV1-SP/CGRP and pyroptosis pathways]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoYang Q +7 more
europepmc +1 more source